Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “REGENERON PHARMACEUTICALS, INC.”

837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 837
Index total 30,257
Page 35 / 35

Quick answer

This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

837 results for “REGENERON PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 6627415

    TIE-2 ligands, methods of making and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 30, 2003 · Expires Sep 25, 2023

    expired
  2. US 6610510

    Morphogenic proteins

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 26, 2003 · Expires Aug 21, 2023

    expired
  3. US 6602687

    DNA encoding human ciliary neurotrophic factor and method for producing the protein encoded thereby

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 5, 2003 · Expires Jul 31, 2023

    expired
  4. US 6602683

    Biologically active Eph family ligands

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 5, 2003 · Expires Jul 31, 2023

    expired
  5. US 6472179

    Receptor based antagonists and methods of making and using

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 29, 2002 · Expires Oct 24, 2022

    expired
  6. US 6472178

    Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 29, 2002 · Expires Oct 24, 2022

    expired
  7. US 6455035

    Angiopoietins and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 24, 2002 · Expires Sep 19, 2022

    expired
  8. US 6440702

    Nucleic acids encoding modified ciliary neurotrophic factors

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2002 · Expires Aug 22, 2022

    expired
  9. US 6441137

    Expressed ligand-vascular intercellular signalling molecule

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2002 · Expires Aug 22, 2022

    expired
  10. US 6432667

    Polynucleotide encoding TIE-2 ligand-4

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 13, 2002 · Expires Aug 8, 2022

    expired
  11. US 6433143

    Tie-2 ligands

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 13, 2002 · Expires Aug 8, 2022

    expired
  12. US 6413740

    Tyrosine kinase receptors and ligands

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 2, 2002 · Expires Jun 27, 2022

    expired
  13. US 6410510

    Administration modified ciliary neurotrophic factors

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 25, 2002 · Expires Jun 20, 2022

    expired
  14. US 6316206

    Method for screening comprising cells expressing the CNTF receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 13, 2001 · Expires Nov 8, 2021

    expired
  15. US 6265564

    Expressed ligand-vascular intercellular signalling molecule

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 24, 2001 · Expires Jul 19, 2021

    expired
  16. US 6207413

    Nucleic acids encoding novel orphan cytokine receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 27, 2001 · Expires Mar 22, 2021

    expired
  17. US 6166185

    Antibodies to human TIE-2 ligands

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired
  18. US 6143714

    Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 7, 2000 · Expires Nov 2, 2020

    expired
  19. US 6077829

    Stable pharmaceutical composition of BDNF

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 20, 2000 · Expires Jun 15, 2020

    expired
  20. US 6060276

    Nucleic acids encoding novel orphan cytokine receptors

    REGENERON PHARMACEUTICALS, INC. · Granted May 9, 2000 · Expires May 4, 2020

    expired
  21. US 6022694

    Assay for ligands to tyrosine kinase receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 8, 2000 · Expires Feb 3, 2020

    expired